UPS Agrees to Acquire Smartways Logistics

The deal would add a healthcare logistics provider serving Australia and New Zealand to UPS Healthcare's network.

Updated on Nov. 17, 2026 in Healthcare

UPS Agrees to Acquire Smartways Logistics

UPS has agreed to acquire Smartways Logistics, a healthcare logistics provider serving Australia and New Zealand. The value and terms of the transaction have not been disclosed.

Why it matters

The acquisition is intended to strengthen UPS Healthcare's time-critical transportation capabilities in the region, according to UPS. It forms part of a broader UPS strategy to invest in healthcare capabilities across Asia Pacific.

UPS Healthcare reported $3 billion in quarterly revenue for the third consecutive quarter in Q3, while Smartways employs more than 350 drivers serving Australia and New Zealand. The purchase price has not been disclosed, and the deal is expected to close in the first half of 2027 pending regulatory approval.

The players

UPS

United Parcel Service is a global logistics company operating in roughly 200 countries and territories, with about 460,000 employees and UPS Healthcare as one of its specialized divisions.

Smartways Logistics

Smartways Logistics is a healthcare logistics provider serving customers in Australia and New Zealand with specialized transport for clinical trials, medical devices and radiopharmaceuticals.

The details

Smartways provides specialized services for life sciences, medical devices, clinical trials and radiopharmaceuticals, using next flight out, same day ground, overnight transportation, reverse logistics and 3PL solutions. UPS said the company will be integrated into its healthcare operations, which already include more than 21 million square feet of cGMP and GDP-compliant distribution space globally.

Timeline

  1. Q3: UPS Healthcare revenue reached $3 billion for the third consecutive quarter.

  2. First half of 2027: Expected closing of the Smartways acquisition, subject to regulatory reviews.

Market Landscape

The deal extends UPS Healthcare's compliant distribution footprint, which already spans more than 21 million square feet globally, into the Australia and New Zealand market. It also follows UPS's recent opening of its Clark hub in the Philippines, signaling a sustained push to compete for life sciences logistics across Asia Pacific.

For patients and healthcare providers in Australia and New Zealand, the acquisition may affect the speed and reliability of shipments for clinical trial materials and medical devices. Customers of Smartways should expect service to continue under the same offerings until the transaction closes.

The takeaway

Healthcare logistics is increasingly a differentiator, so providers that combine time-critical transport with regulatory-compliant storage are gaining ground. Companies that depend on temperature-sensitive or clinical shipments should review their carrier options as consolidation continues.

What happens next

The transaction is expected to close in the first half of 2027, subject to customary regulatory reviews and approvals.

Further reading

For broader context on how logistics providers are expanding their pharmaceutical and clinical supply capabilities, see Healthcare.